Feedback (LON:FDBK) Shares Down 11.5% – Time to Sell?

Shares of Feedback plc (LON:FDBK) were down 11.5% on Monday . The company traded as low as GBX 11 and last traded at GBX 11.50. Approximately 80,531 shares were traded during trading, a decline of 34% from the average daily volume of 121,994 shares. The stock had previously closed at GBX 13.

Feedback Price Performance

The firm has a 50-day simple moving average of GBX 9.27 and a 200 day simple moving average of GBX 11.07. The stock has a market capitalization of £4.83 million, a P/E ratio of -0.43 and a beta of 0.77.

Insider Buying and Selling

In other Feedback news, insider Emma Oswick (Stuart) purchased 60,459 shares of the firm’s stock in a transaction on Tuesday, December 23rd. The stock was purchased at an average cost of GBX 8 per share, for a total transaction of £4,836.72. Also, insider Tom Oakley purchased 60,904 shares of the company’s stock in a transaction dated Tuesday, December 23rd. The shares were acquired at an average cost of GBX 8 per share, with a total value of £4,872.32. 7.98% of the stock is owned by company insiders.

Feedback Company Profile

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.